| An update on the clinical consequences of polypharmacy in older adults: a narrative review JW Wastesson, L Morin, ECK Tan, K Johnell Expert opinion on drug safety 17 (12), 1185-1196, 2018 | 475 | 2018 |
| The epidemiology of polypharmacy in older adults: register-based prospective cohort study L Morin, K Johnell, ML Laroche, J Fastbom, JW Wastesson Clinical epidemiology, 289-298, 2018 | 374 | 2018 |
| The rise and fall of women’s advantage: a comparison of national trends in life expectancy at age 65 years M Thorslund, JW Wastesson, N Agahi, M Lagergren, MG Parker European journal of ageing 10, 271-277, 2013 | 100 | 2013 |
| Indicators of job strain at midlife and cognitive functioning in advanced old age R Andel, M Crowe, I Kåreholt, J Wastesson, MG Parker Journals of Gerontology Series B: Psychological Sciences and Social Sciences …, 2011 | 93 | 2011 |
| The composition of polypharmacy: a register-based study of Swedes aged 75 years and older JW Wastesson, A Cedazo Minguez, J Fastbom, S Maioli, K Johnell PloS one 13 (3), e0194892, 2018 | 72 | 2018 |
| How chronic is polypharmacy in old age? A longitudinal nationwide cohort study JW Wastesson, L Morin, ML Laroche, K Johnell Journal of the American Geriatrics Society 67 (3), 455-462, 2019 | 69 | 2019 |
| Drug use in centenarians compared with nonagenarians and octogenarians in Sweden: a nationwide register-based study JW Wastesson, MG Parker, J Fastbom, M Thorslund, K Johnell Age and Ageing 41 (2), 218-224, 2012 | 67 | 2012 |
| Polypharmacy and injurious falls in older adults: a nationwide nested case-control study L Morin, A Calderon Larrañaga, AK Welmer, D Rizzuto, JW Wastesson, ... Clinical epidemiology, 483-493, 2019 | 61 | 2019 |
| Remaining life expectancy with and without polypharmacy: a register-based study of Swedes aged 65 years and older JW Wastesson, V Canudas-Romo, R Lindahl-Jacobsen, K Johnell Journal of the American medical directors association 17 (1), 31-35, 2016 | 61 | 2016 |
| Trends in use of paracetamol in the Nordic countries JW Wastesson, JE Martikainen, H Zoëga, M Schmidt, Ø Karlstad, ... Basic & Clinical Pharmacology & Toxicology 123 (3), 301-307, 2018 | 55 | 2018 |
| How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study L Morin, JW Wastesson, ML Laroche, J Fastbom, K Johnell Palliative medicine 33 (8), 1080-1090, 2019 | 44 | 2019 |
| Research priorities for optimizing geriatric pharmacotherapy: an international consensus ECK Tan, JK Sluggett, K Johnell, G Onder, M Elseviers, L Morin, ... Journal of the American Medical Directors Association 19 (3), 193-199, 2018 | 44 | 2018 |
| Preventive drugs in the last year of life of older adults with cancer: is there room for deprescribing? L Morin, A Todd, S Barclay, JW Wastesson, J Fastbom, K Johnell Cancer 125 (13), 2309-2317, 2019 | 41 | 2019 |
| Long-term care use during the last 2 years of life in Sweden: implications for policy to address increased population aging B Meinow, JW Wastesson, I Kåreholt, S Kelfve Journal of the American Medical Directors Association 21 (6), 799-805, 2020 | 33 | 2020 |
| Nonaspirin nonsteroidal antiinflammatory drug use in the Nordic countries from a cardiovascular risk perspective, 2000–2016: a drug utilization study KB Kristensen, Ø Karlstad, JE Martikainen, A Pottegård, JW Wastesson, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (2 …, 2019 | 29 | 2019 |
| Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study JW Wastesson, G Ringbäck Weitoft, MG Parker, K Johnell Osteoporosis International 24, 433-442, 2013 | 25 | 2013 |
| Growing income-based inequalities in old-age life expectancy in Sweden, 2006–2015 S Fors, JW Wastesson, L Morin Demography 58 (6), 2117-2138, 2021 | 24 | 2021 |
| Inequalities in health care use among older adults in Sweden 1992–2011: a repeated cross-sectional study of Swedes aged 77 years and older JW Wastesson, S Fors, MG Parker, K Johnell Scandinavian journal of public health 42 (8), 795-803, 2014 | 23 | 2014 |
| Changes in drug use and polypharmacy after the age of 90: a longitudinal study of the Danish 1905 cohort JW Wastesson, A Oksuzyan, J von Bornemann Hjelmborg, K Christensen Journal of the American Geriatrics Society 65 (1), 160-164, 2017 | 19 | 2017 |
| The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018; 10: 289–98 L Morin, K Johnell, ML Laroche, J Fastbom, JW Wastesson Epub 2018/03/22, 0 | 19 | |
Lucas MorinInserm CIC 1431 (CHU Besançon)Verified email at inserm.fr
